Literature DB >> 20176019

Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin.

Kristin K Brown1, Andrew G Cox, Mark B Hampton.   

Abstract

Mitochondrial peroxiredoxin 3 (Prx 3) is rapidly oxidized in cells exposed to phenethyl isothiocyanate (PEITC) and auranofin (AFN), but the mechanism of oxidation is unclear. Using HL-60 cells deplete of mitochondrial DNA we show that peroxiredoxin 3 oxidation and cytotoxicity requires a functional respiratory chain. Thioredoxin reductase (TrxR) could be inhibited by up to 90% by auranofin without direct oxidation of peroxiredoxin 3. However, inhibition of thioredoxin reductase promoted peroxiredoxin 3 oxidation and cytotoxicity in combination with phenethyl isothiocyanate or antimycin A. We conclude that rapid peroxiredoxin 3 oxidation occurs as a consequence of increased oxidant production from the mitochondrial respiratory chain. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176019     DOI: 10.1016/j.febslet.2010.02.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

Review 2.  The biological activity of auranofin: implications for novel treatment of diseases.

Authors:  J M Madeira; D L Gibson; W F Kean; A Klegeris
Journal:  Inflammopharmacology       Date:  2012-09-11       Impact factor: 4.473

Review 3.  Proteins as binding targets of isothiocyanates in cancer prevention.

Authors:  Lixin Mi; Anthony J Di Pasqua; Fung-Lung Chung
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

4.  Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.

Authors:  Marijke C C Sachweh; William C Stafford; Catherine J Drummond; Anna R McCarthy; Maureen Higgins; Johanna Campbell; Bertha Brodin; Elias S J Arnér; Sonia Laín
Journal:  Oncotarget       Date:  2015-06-30

5.  Detoxification of Mitochondrial Oxidants and Apoptotic Signaling Are Facilitated by Thioredoxin-2 and Peroxiredoxin-3 during Hyperoxic Injury.

Authors:  Benjamin J Forred; Darwin R Daugaard; Brianna K Titus; Ryan R Wood; Miranda J Floen; Michelle L Booze; Peter F Vitiello
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

6.  Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.

Authors:  Arya Sobhakumari; Laurie Love-Homan; Elise V M Fletcher; Sean M Martin; Arlene D Parsons; Douglas R Spitz; C Michael Knudson; Andrean L Simons
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

7.  Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State.

Authors:  Alessandra Folda; Anna Citta; Valeria Scalcon; Tito Calì; Francesco Zonta; Guido Scutari; Alberto Bindoli; Maria Pia Rigobello
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

8.  In vitro antineoplastic effects of auranofin in canine lymphoma cells.

Authors:  Hong Zhang; Barbara J Rose; Alex A Pyuen; Douglas H Thamm
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

Review 9.  Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?

Authors:  Jesse Fischer; Tim W Eglinton; Frank A Frizelle; Mark B Hampton
Journal:  Antioxidants (Basel)       Date:  2018-10-05

Review 10.  NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation.

Authors:  Evan L Carpenter; Alyssa L Becker; Arup K Indra
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.